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1Promotion of Mefenamic acid Nucleation by a 
Surfactant Additive, Docusate Sodium
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Bernal Institute, University of Limerick, Limerick V94 T9PX, Ireland
* E-mail: Ake.Rasmuson@ul.ie
ABSTRACT: The influence of docusate sodium (DOSS) on the nucleation of mefenamic acid 
(MEF) has been studied in different dimethylacetamide (DMA) – water mixtures. A series of 
induction time experiments were conducted under moderate supersaturations, varying the solvent 
composition and the concentration of DOSS. In 40 % DMA – 60 % water, the presence of 0.1 
mg/mL and 0.2 mg/mL DOSS increased the nucleation rate. Evaluating the results by the 
classical nucleation theory reveals that the pre-exponential factor (A) increases by approximately 
50 % while the interfacial energy is essentially uninfluenced. It is also found that the crystal 
growth rate becomes higher in the presence of DOSS. It is thus hypothesized that transport and 
desolvation of MEF molecules is facilitated in the presence of DOSS. With increasing amount of 
DMA in the binary solvent mixture, the influence of DOSS appears to decrease.
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21. INTRODUCTION
Many potential drug candidates have poor water solubility and slow dissolution rates in vivo, 
leading to limited bioavailability and failure to reach the market1. Antisolvent precipitation is a 
potential low-energy crystallization method for the industrial production of drug nanocrystals 
with an improved bioavailability2. Additives are generally used in the process to promote 
nucleation, inhibit crystal growth and stabilize the system against subsequent particle 
transformation3,4. Specifically, enhancement of nucleation can decrease the initial crystal size. By 
increasing the rate of nucleation, a higher number of nuclei forms and thus, smaller crystal sizes 
can be achieved. However, the identification of suitable additives for each drug is challenging 
due to the lack of knowledge about the specific action of different additives in the nanocrystal 
preparation process.
The mechanisms by which additives promote the nucleation of a compound is a topic of 
intensive interest in the crystallization community5. It is known that the presence of a larger 
amount of additive can decrease the solubility of a compound, increasing the thermodynamic 
driving force for nucleation. Recently, Mochizuki et al.6 found that even low concentration of 
additives could promote homogeneous nucleation of ice through increasing the activity of water 
in solution. Electrolytes were found to promote the nucleation of glycine7 and DL-alanine8 by 
inducing a head-to-tail molecular ordering. Computational and theoretical studies9,10,11,12 propose 
that surfactant type or surface active oligomeric additives can reduce the nucleus – solution 
interfacial energy and thus, reduce the nucleation work upon adsorption to the interface. In 
addition, additives that can stabilize the nuclei may act as heterogeneous nucleation centres13,14,15.
There are only a limited number of studies showing direct experimental evidence of the 
promotion of nucleation of organic compounds by soluble organic additives. Kim and co-
workers16 conducted induction time experiments using moderate supersaturations and found that 
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3amphiphilic additives promoted the nucleation of the hexahydro-1,3,5-trinitro-1,3,5-triazine 
molecule. However, the results showed an increasing nucleation rate over time in contrast to a 
stationary rate assumed by the classical nucleation theory and thus, they were unable to estimate 
interfacial energy values for the studied systems. Poornachary et al.17 found that 
polyvinylpyrrolidone (PVP) promoted the nucleation of naproxen crystals by increasing the pre-
exponential factor with an insignificant change in the thermodynamic parameter and thus, 
interfacial energy for nucleation. The authors concluded that PVP acted as a heterogeneous 
nucleation centre in the crystallization process.
In an earlier study18, an anionic surfactant, docusate sodium (DOSS), had to be added to 
produce nanocrystals of a poorly water-soluble compound, mefenamic acid (MEF), during an 
antisolvent precipitation process in 5 % dimethylacetamide (DMA) – 95 % water system. Since 
the final size of the nucleating crystals is governed by the number of formed nuclei and thus, the 
nucleation rate, the reduction of the crystal size suggested that DOSS accelerated the nucleation 
of MEF. The approximately threefold reduction of the crystal volume in the presence of 1 mg/mL 
DOSS corresponds to a threefold increase in the number of formed nuclei, suggesting an 
approximately threefold increase of the nucleation rate. An increase in nucleation rate by the 
addition of additives is less commonly encountered than the opposite, so experimental evidence 
that the nucleation rate actually increased is needed. In order to produce nanocrystals of MEF, a 
very high supersaturation needs to be generated. This was achieved by using a high water 
concentration as MEF is essentially insoluble in water. However, at these conditions the 
induction time is extremely short and thus difficult to measure with sufficient accuracy. In 
addition, primary nucleation is a highly stochastic process and thus the nucleation rate at each 
condition must be recorded in repeated experiments. Commonly this is done in parallel cooling 
crystallization experiments where 10 – 30 experiments on the millilitre scale are observed 
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4simultaneously at isothermal conditions after the creation of supersaturation19,20,21 and where the 
cooling and reheating can be cycled to collect perhaps a hundred recordings of the induction time 
at each condition. However, supersaturation generation by cooling can only be used for induction 
times in the order of minutes and longer, at lower supersaturations and water content of the 
solutions, and thus not for the supersaturation experiments used in the nanocrystal manufacturing 
method for mefenamic acid. Measurement of shorter induction times at higher supersaturations, 
in solutions having a higher concentration of water, requires an antisolvent method. However, to 
operate 50 – 100 repeated antisolvent experiments is of course much more demanding as the 
antisolvent needs to be injected in every individual vial, and the experiment cannot be repeated 
without replacing the solution with fresh material.
In this work, the influence of DOSS on the nucleation of a MEF solution is studied with the 
aim being to elucidate the action of DOSS in the nanocrystal formation process of MEF. A series 
of induction time experiments were performed at isothermal conditions in the absence or 
presence of DOSS, varying the supersaturation and the ratio of the drug to the additive. Initially, 
supersaturation was created using the conventional cooling crystallization method in 70 % DMA 
– 30 % water solvent system. This allowed for parallel crystallization experiments of up to 15 
vials to be performed and recycling of the solution, significantly reducing chemical waste and 
labour expenses. However, no influence of DOSS on the nucleation rate was found perhaps 
related to the much higher DMA content and lower supersaturations compared to the originally 
used conditions during the preparation of MEF nanocrystals18. A more laborious antisolvent 
crystallization method17, where the solutions had to be mixed in each separate vial to achieve a 
desired composition, allowed for the study of significantly shorter induction times in 40 % DMA 
– 60 % water solvent mixtures and at higher levels of supersaturation. Under these latter 
conditions, DOSS enhanced the nucleation of MEF. The results are analyzed within the 
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5framework of the classical nucleation theory (CNT), and a mechanism for the nucleation 
enhancement and the influence of solvent composition is proposed.
2. THEORY
According to CNT, the stationary rate of primary crystal nucleation, J, is defined as the 
number of crystals formed per a unit volume and time, and can be expressed as 22,23,24: 
(1)* * * 0 exp
GJ zf C zf C
kT
     
where C* is the equilibrium concentration of critical nuclei, f* is the frequency of attachment of 
building units to the critical nucleus and z is the Zeldovich factor. The term C* includes the 
thermodynamic information about the nucleation process, being the product of the concentration 
of nucleation sites in the system, C0, and an exponential term containing the free energy barrier, 
ΔG, that must be surpassed for nucleation to occur as well as the Boltzmann constant (k) and 
absolute temperature (T). For homogeneous nucleation assuming a spherical nucleus, ΔG can be 
expressed as22:
(2)
2 3
2 2
16
3 ( ) ln
mG
kT S
  
where υm is the volume of a molecule in the crystal, γ is the interfacial energy and S is the 
supersaturation, calculated in this paper by dividing the molar concentration (mol/L) of the 
molecules in the supersaturated solution with the equilibrium concentration. Note that the ratio of 
concentrations in the unit of mol/L for the same compound is equal to the ratio of concentrations 
in the unit of mg/mL, which concentration unit is also used herein for easier representation of the 
data.
The Zeldovich factor can be written as22:
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6 (3)
3
2
3
2
2ln ( )
8 m
S kTz  
Attachment of monomers occurs by diffusion of the solute in the bulk solution towards the 
nucleus and by transferring the solute from the vicinity of the nucleus to a position incorporated 
in the nucleus. Assuming interface transfer control, the attachment frequency can be expressed 
as22:
(4) 
1 3
5/3 2
2 2
48
3 lnm eq
D Sf A c c D
d kT S
           
where λ is the sticking coefficient accounting for the molecules in the vicinity of the nucleus that 
do not adsorb to the nucleus, A* is the surface of the nucleus, c is the concentration of the 
monomers in the solution, d is the distance of the jump that could be approximated by the 
molecular diameter and D is the diffusion coefficient. D can be expressed with an Arrhenius type 
equation (D=D0exp(-ΔE/kT))23 where E describes an energy barrier associated with a 
desolvation process and/or conformational change of the molecule during incorporation into the 
nucleus. Expressing c using S and elaborating the term A* for a spherical nuclei provides the form 
of the attachment frequency on the right hand side of the formula.
The above equations for the free energy barrier (2), Zeldovich factor (3), and attachment 
frequency (4) are derived assuming homogeneous nucleation and spherical nuclei. It is possible, 
however, that heterogeneous nucleation occurs on a surface that can stabilise the nucleus by 
lowering the interfacial energy and thus, the energy barrier for nucleation. For heterogeneous 
nucleation, the above formulas can be used by replacing the interfacial energy with an effective 
interfacial energy accounting for the influence of the heterogeneous surface22. The geometry of a 
non-spherical nucleus can be also considered by using numerical corrections. 
By combining (1)-(4), the nucleation rate can be expressed as22: 
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7(5)2exp ln
BJ AS
S
    
3. MATERIALS AND METHODS
The experimental work of this study includes determination of the solubility of mefenamic 
acid polymorphs (stable Form I and where relevant, metastable Form II) and nucleation induction 
times in 40 % DMA – 60 % water and in 70 % DMA – 30 % water, in the presence and absence 
of the surfactant docusate sodium. In the nucleation experiments the supersaturation is generated 
by antisolvent addition or cooling, respectively. For both solvent systems, the crystallized solid 
has been isolated for determination of the polymorphic form. In the 40 % DMA – 60 % water 
mixture, also the timescale of transformation of Form II to Form I has been studied.
3.1. Materials
Mefenamic acid (MEF, Form I, >98 %), N,N-dimethylacetamide (DMA, >99.9 %), 
acetonitrile (ACN), acetic acid, sodium docusate (dioctyl sulfosuccinate sodium salt, DOSS), and 
sodium acetate were obtained from Sigma Aldrich. Tetrahydrofuran (THF) was purchased from 
VWR. Deionized water was used for aqueous solutions (18 MΩ, ELGA, Purelab Ultra). All 
chemicals were used as received. 
The metastable polymorphic form, MEF Form II, was prepared as a reference 
material by heating the as received MEF Form I to 160 ˚C for 48 hours25. The structural 
purity of the product was examined by PXRD and FTIR. 
3.2. Solubility Studies
The solubility of the stable MEF polymorph, Form I in 40 % DMA – 60 % water (v/v) was 
determined at the crystallization temperature (Tcryst) of 25 °C in the absence and presence of 0.2 
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8mg/mL DOSS from six separate solubility experiments. Here v/v % represents the volume 
fraction of solvents mixed for creating the specific cosolvent system. The solubility of Form I in 
70 % DMA – 30 % water (v/v) was measured at the crystallization temperature (Tcryst) of 15 °C 
in the presence of 0-5 mg/mL DOSS, as well as at 20 °C, 30 °C and 35 °C in the absence of 
DOSS to estimate the saturation temperature (Tsat) at which a solution with a given concentration 
is saturated. In this solvent system, three separate solubility experiments were done at each 
condition of DOSS concentration and temperature. In all cases, solutions were saturated by 
adding an excess of Form I solid to the corresponding solvent mixture and placing into a water 
bath (Grant GR150, accuracy ± 0.1 ˚C) under magnetic stirring at 400 rpm. After 24 h, the stirrer 
was switched off and the suspensions were left to settle for 24 h. From each solution a 2 mL 
sample was then filtered with nylon (with 40 % DMA) or polytetrafluoroethylene (PTFE) (with 
70 % DMA) syringe filters (0.2 µm pore size, VWR), discarding the first mL to avoid possible 
adsorption of the MEF molecules to the filter membrane. While a hydrophilic nylon membrane 
was suitable for filtering solutions containing 60 % water, an organic solvent resistant PTFE was 
used to avoid possible degradation of the filter material with 70 % DMA. In case of both solvent 
systems, the filtrate was diluted with 70 % DMA – 30 % water and analyzed using an Agilent 
high performance liquid chromatography system (HPLC) at a detection wavelength of 285 nm. 
The mobile phase consisted of 55 % sodium acetate buffer at 50 mM, pH 5 and 45 % ACN:THF 
(23:7) solvent mixture. The chromatographic separation was carried out using a reverse phase C8 
column (250 mm x 4.6 mm) and 1 mL/min flow rate. The volume of the injected sample was 20 
µL. Powder X-ray diffraction experiments verified that the crystalline state of the suspended 
MEF Form I did not change during the equilibration. 
The determination of the solubility of the metastable Form II polymorph is more challenging 
because of the tendency for polymorphic transformation. Thus in the present work, the solubility 
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9of Form II crystals was estimated from the mole fraction solubility ratio (xII/xI) determined by 
Romero et al.26 at 25.0 ºC in different solvents, as this value is almost independent of the choice 
of solvent, representing the relative stability of the forms at a certain temperature (fundamental 
justification is given in Supporting Information). The mole fraction solubility ratio of MEF Form 
II and Form I at 25.0 ºC was reported to be 1.37 in water, 1.40 in ethanol and 1.28 in ethyl 
acetate26. Considering that polymorphic transformation is the fastest when the solubility is the 
highest, i.e. in ethyl acetate26, and the solubility determination is more uncertain at low solubility, 
i.e. in water26, the highest mole fraction solubility ratio measured in ethanol, 1.40, has been 
selected for the solubility calculation of MEF Form II at 25.0 ºC. 
In 40 % DMA – 60 % water at 25.0 ºC, the solubility of the stable MEF Form I was 0.065 ± 
0.003 mg/mL, and remained the same in the presence of 0.2 mg/mL DOSS (Table 1). The 
solubility of the metastable MEF Form II was calculated to be 0.091 ± 0.004 mg/mL. In 70 % 
DMA – 30 % water the solubility of MEF Form I at 15.0 ºC was 3.80 ± 0.01 mg/mL and did not 
change in the presence of 1 mg/mL DOSS but increased slightly to 3.92 ± 0.03 mg/mL in the 
presence of 5 mg/mL DOSS. The solubility in 70 % DMA – 30 % water in the absence of DOSS 
determined at different temperatures are graphed on Figure S1 (Supporting Information) along 
with an exponential fit to calculate Form I saturation temperatures for any given concentration 
relevant to supersaturation generation by cooling crystallization.
Table 1 Solubility of MEF in 40 % DMA – 60 % water at 25 °C and in 70 % DMA – 30 % water 
at 15 °C in the absence and presence of different concentrations of DOSS. Standard deviation is 
calculated from six (40 % DMA – 60 % w) or three (70 % DMA – 30 % w) repeat of the entire 
solubility determination experiment.
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10
Solubility in 40 % DMA – 60 % w 
at 25 °C / mg·mL-1
Solubility in 70 % DMA – 30 % w 
at 15 °C / mg·mL-1DOSS / 
mg·mL-1
Form I Form II Form I
0 0.065 ± 0.003 0.091 ± 0.004* 3.80 ± 0.01
0.1 - - 3.81 ± 0.01
0.2 0.065 ± 0.001 0.091 ± 0.002* -
1 - - 3.81 ± 0.03
2.5 - - 3.84 ± 0.04
5 - - 3.92 ± 0.03
* calculated from Form I solubility using the mole fraction solubility ratio of xII/xI=1.4
3.3. Induction time experiments
Induction time refers to the time elapsed from the moment of the creation of supersaturation 
until the detection of the first crystals. Two different procedures, antisolvent crystallization (40 % 
DMA – 60 % water) and cooling crystallization, were used to generate supersaturation. Although 
supersaturation generation was different, crystallization occurred at isothermal conditions in both 
crystallization procedures at relatively similar temperatures, providing a basis for the comparison 
of the results. The program of induction time experiments is presented in Table 2, including the 
temperature of crystallization, the polymorphic outcome and supersaturations calculated based on 
the solubility results from Table 1. Throughout the paper, SI denotes supersaturation calculated 
with respect to Form I, whereas SII denotes supersaturation calculated with respect to Form II. 
Polymorphic behavior of the systems, providing a basis for the calculation of supersaturation, is 
presented later, in section 4.1. In both systems, the concentration of DOSS was selected to 
achieve molar ratios comparable to the originally used nDOSS/nMEF= 0.29 during the preparation of 
MEF nanocrystals in 5 % DMA – 95 % water18.
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Table 2. Induction time experiments performed, temperature of crystallization (Tcryst), 
concentration of MEF (cMEF) and DOSS (cDOSS) in the final solvent mixture, the molar ratio of 
DOSS to MEF (nDOSS/nMEF), nucleating polymorphic form and supersaturation (S)
% (v/v) 
of DMA
Generation of 
supersaturation
Tcryst / 
°C
cMEF / 
mg∙mL-1
cDOSS / 
mg∙mL-1 nDOSS/nMEF
Polymorphic 
form S
0 0
0.1 0.140.40
0.2 0.27
Form II 4.40II
0 0
0.1 0.180.30
0.2 0.36
Form II 3.30II
0 0
0.1 0.230.24
0.2 0.45
Form II 2.64II
0 0
0.1 0.27
40 Antisolvent crystallization 25
0.20
0.2 0.54
Form II 2.20II
7.55 0 0 Form I 1.99I
0 0
1 0.08
1.75I
6.66
5 0.41
Form I
1.70I
70 Cooling crystallization 15
5.81 0 0 Form I 1.53I
I S is calculated based on Form I solubility
II S is calculated based on Form II solubility
In the case of the 40 % DMA – 60 % water solvent system, supersaturation (SII=4.40 – 2.20) 
was created by antisolvent crystallization at Tcryst=25.0 °C. MEF solution (solution 1) was 
prepared in 80 % DMA – 20 % water (v/v) and filtered with a PTFE syringe filter (0.2 µm, 
VWR) after overnight stirring. The antisolvent solution (solution 2) consisted of 5.9 mL 
deionised water or aqueous DOSS solution premixed with 3.6 mL DMA. When DOSS was used, 
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12
the antisolvent solution was filtered with a nylon syringe filter (0.2 µm, VWR) to remove 
particulate impurities. For an induction time experiment, 0.5 mL MEF solution (solution 1) was 
pipetted into 9.5 mL antisolvent solution (solution 2) giving a final solvent composition of 40 % 
DMA – 60 % water. The mixed solution was stirred at 300 rpm using a magnetic stir bar and the 
induction time was recorded with a camera. The visually detectable level of the mixing of the two 
phases was complete within 4 s. Since the mixing of DMA and water is highly exothermic, 
premixing of the major part of DMA and water as the antisolvent solution prior the addition of 
MEF solution allowed for the reduction of the initial temperature rise to less than 0.2 °C. The 
recorded videos were analyzed by the naked eye, carefully comparing snapshots prior to and after 
the visual appearance of crystals. The uncertainty of the detection technique itself, estimated from 
repeated analysis of the induction time video for a given vial of nucleating solution is 3-4 seconds 
at SII=4.40, increasing to 5-10 s at SII=2.20. The use of lower supersaturations was restricted due 
to the decreasing turbidity of the system as a result of the lower mass crystallized. A 59-91 data 
points were measured for each condition to account for the stochastic nature of nucleation. 
In the case of 70 % DMA – 30 % water, supersaturation (SI =1.99 – 1.53) was generated by 
cooling the solution below its saturation temperature, to Tcryst=15 °C. A 250 mL stock solution 
was prepared by dissolving a known amount of MEF in the premixed solvent mixture at a Tdiss 
dissolution temperature, 16 °C above the corresponding saturation temperature (Tdiss=Tsat+16 °C) 
using submersible magnetic stirrer plate for mixing (400 rpm, 4 h). Based on solubility results 
(Figure S1 in Supporting Information), Tdiss was 40.0 °C, 42.8 °C and 45.0 °C for SI= 1.53, 
SI=1.75 and SI=1.99, respectively. Then, the solution was filtered with preheated syringes 
equipped with PTFE filters (0.2 µm, VWR) to eliminate particulate impurities. This batch 
solution was subjected to two crystallization cycles prior to recording any induction times (pre-
treatment cycles) in order to overcome history of solution/filtration effects: first crystallization at 
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5 °C followed by dissolution of the crystals at Tdiss (4 h), then crystallization at Tcryst=15 °C 
followed by dissolution of the crystals at Tdiss (3 h). Fifteen mL solutions were then distributed 
into 15 preheated vials containing a magnetic stir bar and left to equilibrate for another 2 h at 
Tdiss. To start the induction time experiments, the vials were placed into a waterbath at 
Tcryst=15 °C and stirrer speed of 250 rpm, and a high resolution camera was started to record the 
induction time by visual inspection. Due to the 3-4 min initial cooling period to the crystallization 
temperature, also measured as a part of the induction time, only supersaturations giving 
sufficiently large induction times (>10 min) could be studied using this method to ensure that 
nucleation occurs at isothermal conditions. After crystallization, the vials were placed back into 
the waterbath at Tdiss for dissolution (5 h) and the crystallization cycle was repeated (Tcryst –Tdiss – 
Tcryst and so on) to collect 90-105 and 60-75 induction time data in the absence and presence of 
DOSS, respectively. 
3.4. Isolation and characterization of the crystals 
In the case of 40 % DMA – 60 % water solvent system, two drying methods have been used to 
understand the polymorphic behavior of the systems.  (1)  At SII=4.40 in the absence of DOSS, 
crystals were isolated by filtration at different times (8 min, 15 min and 3.5 hours) after the first 
detection of crystallization and dried under high vacuum (<27 Pa) at room temperature for 16 h. 
(2) At SII=4.40 and SII=2.20, in the absence and presence of 0.1-0.2 mg/mL DOSS, crystals were 
isolated by filtration, 8 min (in case of SII=4.40) or 15 min (in case of SII=2.20) after the first 
detection of crystallization and dried at 50 °C for 1 h. Due to the very low crystallizing mass, 
these selected times were required to ensure enough sample for characterization. While drying at 
room temperature was employed to slow down polymorphic transformation during drying, the 
obtained crystals were partially defected because of the high vacuum. Thus, the second drying 
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method using higher temperature but atmospheric pressure was used further on to avoid 
sublimation of the crystals. 
In case of 70% DMA – 30 % water, crystals were isolated by filtration, 8 min (SI=1.99) or 15-
20 min (SI=1.75 and SI=1.70) after the first detection of crystallization and dried at 50 °C for 1 
hour. 
The polymorphic form of the crystals, in cases of small crystallization yields, was 
characterized by Fourier transform infrared (IR) spectroscopy, employing a Perkin Elmer 
Spectrum 100 ATR FTIR. Spectra were recorded between 650-4000 cm-1 using 2 cm-1 spectral 
resolution and 32 scan per sample. Three samples were characterized at each condition unless 
otherwise stated. 
The polymorphic form of the crystals nucleated in 70 % DMA – 30 % water at SI=1.99, 
having a larger crystallization yield, was verified using a Philips PANAlytical X’pert powder X-
ray diffractometer. The sample was placed between amorphous tapes and measured in 
transmission geometry using Ni filtered Cu Kα radiation (λ=1.54 Å), 40 kV accelerating voltage 
and 40 mA anode current. The diffraction pattern was collected between 5˚ and 30˚ (2θ) and the 
separately measured diffraction pattern of the amorphous tape was subtracted from the 
diffractogram.
The size and habit of the isolated crystals were analyzed by a HITACHI SU-70 scanning 
electron microscope at 3 kV. To prepare the samples, a small amount of isolated particle was 
placed onto an adhesive carbon tape attached to a cylindrical aluminum sample holder and gold 
sputtered at 20 mA for 1 minute using an EMITECH K550. Two samples were characterized at 
each condition.
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4. RESULTS
4.1. Polymorphic behaviour of the systems
Example IR spectra of the crystals nucleated in 40 % DMA – 60 % water at SII=4.40 and 
SII=2.20 in the absence and presence of 0.1-0.2 mg/mL DOSS and dried at 50 °C are shown in 
Figure 1, whereas additional spectra of repeated samples are shown in Figure S2 (SII=4.40) and in 
Figure S3 (SII=2.20) in the Supporting Information. The stable Form I and the metastable Form II 
polymorphs can be distinguished by the band position associated with the amine stretch25,27, 
being 3308 cm-1 with a shoulder at 3344 cm-1 for Form I and a single peak at 3344 cm-1 for Form 
II. Looking at SII=4.40 in Figure 1 and Figure S2, several samples contain only Form II crystals 
and in case of the mixtures, Form II crystals are dominating with a small amount of Form I. This 
indicates that the metastable Form II crystals are nucleating initially and the stable Form I 
crystals appear as a result of polymorphic transformation. At SII=2.20 shown in Figure 1 and 
Figure S3, the majority of the isolated samples are a mixture of Form II and Form I crystals 
(eight out of nine samples) with one exception at 0.2 mg/mL DOSS being only Form I. The 
higher ratio of Form I crystals in these samples as opposed to at SII=4.40 is likely to be the result 
of longer suspension aging time, being 15 min as opposed to 8 min at SII=4.40. At both 
supersaturations, no clear influence of DOSS on the polymorphic form was observed. 
The timescale of polymorphic transformation was tested at SII=4.40 in the absence of DOSS 
by isolating samples at different times after the detection of crystallization and drying under high 
vacuum at room temperature. Compared to drying at 50 °C (Figure 1), this drying condition 
provided pure Form II samples or samples containing a significantly lower amount of Form I 
crystals when isolated after the same 8 min aging time (Figure S4 in Supporting Information). 
Increasing the aging time to 15 min substantially increased the amount of Form I crystals in the 
sample, and after 3.5 h aging pure Form I crystals or Form I crystals with a very small amount of 
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Form II were obtained. These results verify that the timescale of polymorphic transformation is 
indeed short and even more accelerated by drying at higher temperatures, supporting the 
hypothesis that the presence of Form I crystals in the samples crystallized at SII=4.40 or SII=2.20 
and dried at 50 °C is due to polymorphic transformation. Therefore supersaturation is calculated 
with respect to Form II solubility in 40 % DMA – 60 % water systems.
Figure 1 IR spectra of pure MEF polymorphs and MEF crystals nucleated in the absence or 
presence of DOSS at different supersaturations. At SII=4.40, crystals were isolated at 8 min aging 
time, whereas at SII=2.20, crystals were isolated after 15 min aging time, and crystals were dried 
at 50 °C. SII is calculated based on the solubility of the nucleating Form II crystals. 
In 70 % DMA – 30 % water, in the pure MEF system at SI=1.99, Form I crystals were isolated 
(Figure 2). Since Form I crystals have a weak adsorption band in the IR spectra at the same 
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position as the main band of Form II crystals, 3344 cm-1, the absence of Form II crystals in the 
sample was verified using PXRD (Figure S5 in Supporting Information). At SI=1.75, the addition 
of 1 mg/mL and 5 mg/mL DOSS did not have an influence on the polymorphic form of the 
crystals, yielding Form I crystals in each case. Since only the stable polymorphic form was 
isolated at SI=1.99 and SI=1.75, the crystals at SI=1.53 are also expected to be Form I. Therefore 
supersaturation is calculated with respect to Form I solubility in 70 % DMA – 30 % water 
systems.
Figure 2 IR spectra of pure MEF polymorphs and MEF crystals nucleated in the absence or 
presence of DOSS at different supersaturations. At SI=1.99, crystals were isolated at 8 min aging 
time, whereas at SI=1.75 and 1.70, crystals were isolated after 15-20 min aging time. SI is 
calculated based on the solubility of the nucleating Form I crystals.
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Figure 3 presents SEM images of the crystals obtained from 40 % DMA – 60 % water. Based 
on IR, most of the samples presented herein are a mixture of Form I and Form II crystals (except 
at SII=4.40, 0.1 mg/mL DOSS) with the images focusing on the initially nucleating Form II 
crystals. In the absence of DOSS, Form II crystals had parallelepiped habit at both SII=4.40 and 
SII=2.20, having more evolved facets at SII=2.20. The presence of DOSS, irrespective of the 
concentration used, did not have a noticeable influence on the habit indicating no specific face for 
adsorption of the surfactant molecule. The habit of Form I crystals present in the same samples, 
when found in the case of polymorph mixtures, was distinctly different being plate-like at all 
studied conditions (Figure S6 in Supporting Information). Similarly, in 70 % DMA – 30 % water 
at SI=1.75 in the absence of DOSS, the habit of the Form I crystals was plate-like, and did not 
change upon the addition of 1 mg/mL or 5 mg/mL DOSS (Figure 4.)
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Figure 3 SEM images of MEF crystals prepared in the absence or presence of DOSS in 40 % 
DMA – 60 % water, at SII=4.40 (isolated at 8 min) and at SII=2.20 (isolated at 15 min). Based on 
IR, samples are a mixture of Form I and Form II crystals except at SII=4.40, 0.1 mg/mL DOSS, 
with the images focusing on mainly Form II crystals (parallelepiped shape). SII is calculated 
based on Form I solubility.
Figure 4 SEM images of crystals prepared in the absence and presence of DOSS in 70 % DMA – 
30 % water. Crystals were isolated after 15-20 min aging and are pure Form I. SI is calculated 
based on Form I solubility.
4.2. Induction time probability distributions
Figure 5 shows the experimental probability distribution of induction times of MEF in 40 % 
DMA – 60 % water at SII=4.40-2.20 in the absence or presence of 0.1 mg/mL and 0.2 mg/mL 
DOSS. For each system, the induction times and the width of the distributions are systematically 
increasing with decreasing supersaturation, where the scattering of the data is attributed to the 
inherent stochasticity of nucleation events28,29,30 and influenced by the experimental technique 
used31. In the absence of DOSS, the measured induction times were in the range of 27 s – 74 s at 
SII=4.40 and increased to 92 s – 370 s with decreasing the supersaturation to SII=2.20. In the 
presence of DOSS, overall shorter induction times were measured at each supersaturation 
examined but the measured distributions did not depend on the DOSS concentration.
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Figure 5 Experimental probability distributions of induction times of MEF in the absence or 
presence of DOSS at different supersaturations. Green triangle ( ): pure MEF; blue circle ( ): 
MEF with 0.1 mg/mL DOSS; red rhombus ( ): MEF with 0.2 mg/mL DOSS. The fit to equation 
(6), described in section 4.3, is also shown. SII is calculated based on the solubility of the 
nucleating Form II crystals.
In a 70 % DMA – 30 % water solvent mixture, presented in Figure 6, the induction times 
varied from ten minutes to hours at SI=1.99-1.53, in contrast to induction times of couple of ten 
seconds to minutes measured in 40 % DMA – 60 % water systems at higher supersaturations. At 
SI=1.75, the addition of 1 mg/mL DOSS only slightly shifted the distribution to longer induction 
times compared to the pure system. In the presence of 5 mg/mL, the supersaturation decreased 
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from SI=1 .75 to SI =1 .70 at the same concentration of MEF due to the increase in solubility. The 
corresponding induction time distribution was shifted to longer induction times compared to the 
two systems at SI=1.75. 
Figure 6 Experimental probability distributions of induction times of MEF in the absence or 
presence of DOSS at different supersaturations in 70 % DMA – 30 % water. Dark green triangle (
): pure MEF at SI=1.99; green circle ( ): pure MEF at SI=1.75; light green square ( ): pure MEF 
at SI=1.53; orange rhombus ( ): MEF with 1 mg/mL DOSS at SI=1.75; red triangle ( ): MEF 
with 5 mg/mL DOSS at SI=1.70. Fit to equation (6), described in section 4.3, is also shown. SI is 
calculated based on the solubility of the nucleating Form I crystals.
4.3. Nucleation rate determination
Assuming independent nucleation events and a single nucleus mechanism, the induction time 
distributions can be described with a homogeneous Poisson distribution, where the probability of 
detection of a nucleation event P(t) within a time t is21,24,32:
(6)     1 exp gP t J V t t    
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Where J is the nucleation rate, V is the solution volume and tg is the growth time. The growth 
time accounts for the time difference between the detection of nucleation (t) and the actual 
nucleation event (t-tg), with the assumption that the shortest nucleation time is 0 s (t=tg). Tables 3 
and 4 summarize J and tg obtained from fitting equation (6) to the experimental probability 
distributions presented in Figure 5 and 6, respectively. In 40 % DMA – 60 % water, R2 values 
describing the quality of the fit were in the range of 0.89-0.99, being lower at higher 
supersaturations, whereas in 70 % DMA – 30 % water, a fairly good R2 ≥ 0.95 was found at all 
conditions.
In 40 % DMA – 60 % water (Table 3), in the presence of DOSS, the nucleation rate increased 
by 37-51 %, while the growth time decreased by 13-22 % compared to the pure system in the 
range of SII=2.20-3.30, with no major difference between the studied DOSS concentrations. At 
SII=4.40, the experimental induction time distributions from Figure 5 shows the same trend. 
However, the analysis, Table 3, lead to significantly lower nucleation rate at SII=4.40 in the 
presence of 0.1 mg/mL DOSS than in the presence of 0.2 mg/mL DOSS or in the absence of 
DOSS. These outlying data points arise from the increasing uncertainty of the results with 
increasing supersaturation and the lowest accuracy of the Poisson fit at SII=4.40 in the presence 
of 0.1 mg/mL DOSS (R2=0.89). 
As a comparison, to verify the same influence of DOSS at SII=4.40 as at SII=3.30-2.20, we 
also determined J from fitting a lognormal cumulative distribution function (LCDF)20,33: 
(7)   0.5erfc(-(ln ) / 2)P t t   
to the cumulative induction time distributions, where the location parameter η can be translated to 
the geometric mean (=median induction time, t50) by exp (η) = t50 and the scale parameter σ to the 
geometric standard deviation (σ*) by exp (σ) = σ*. The nucleation rate, included in Table 3, can be 
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calculated from the median induction time and solution volume by J = 1/t50V. Compared to J 
values obtained using the Poisson function (6), using LCDF resulted in a similar trend in the 
range of SII=2.20-3.30, with values being 47-55 % smaller. This trend also extended to SII=4.40, 
showing higher and comparable nucleation rates in the presence of both concentration of DOSS 
than in the absence of it. The difference in the nucleation rates calculated by fitting a Poisson 
distribution and the LCDF derives primarily from the fact that the latter method assumes that the 
time to grow to visibility is negligible. Thus, the nucleation time is approximated by the 
induction time, and the nucleation rate is calculated from the median induction time. This results 
in larger nucleation times and thus, lower nucleation rates. However, in these systems, it appears 
as if the growth time is not negligible and thus, the LCDF analysis is primarily presented to 
qualitatively verify the trend in nucleation rates at different supersaturations and DOSS 
concentrations, as this analysis is less sensitive to the shape of induction time distribution than 
the Poisson analysis.  
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Table 3. Nucleation rate, J, and growth time, tg, of MEF at different SII supersaturations in the 
absence or presence of DOSS in 40 % DMA – 60 % water, from fitting to equation (6). As a 
comparison, the median induction time t50a and the nucleation rate Ja from fitting to equation (7) 
is also shown. SII is calculated based on the solubility of the nucleating Form II crystals.
SII DOSS / mg·mL-1
Molar ratio 
nDOSS/nMEF
J 
/m-3s-1
tg 
/s
t50a
/s
Ja 
/m-3s-1
4.40 0.0 0 6270 28.8 40.9 2448
4.40 0.1 0.14 5784 20.8 33.5 2982
4.40 0.2 0.27 7025 23.0 33.8 2956
3.30 0.0 0 2861 40.6 65.6 1524
3.30 0.1 0.18 4061 33.9 52.6 1901
3.30 0.2 0.36 4027 34.7 52.9 1890
2.64 0.0 0 1859 66.3 106.2 941
2.64 0.1 0.23 2799 51.6 78.8 1267
2.64 0.2 0.45 2606 50.7 78.9 1267
2.20 0.0 0 1109 111.4 177.1 565
2.20 0.1 0.27 1517 96.8 145.2 689
2.20 0.2 0.54 1524 90.5 141.3 723
In 70 % DMA – 30 % water at SI=1.99-1.53 (Table 4), the nucleation rates determined by 
fitting the Poisson function were orders of magnitude lower and the growth times larger 
compared to those measured at higher supersaturations in 40 % DMA – 60 % water. At SI=1.75, 
compared to the pure system, the addition of 1 mg/mL DOSS only slightly decreased the 
nucleation rate by 7 %, but increased the growth time by 20 %. At SI=1.70 in the presence of 5 
mg/mL DOSS, the nucleation rate was further decreased and the growth time increased, possibly 
just because of the lower supersaturation. 
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Table 4. Nucleation rate, J, and growth time, tg, of MEF at different SI supersaturations in the 
absence or presence of DOSS in 70 % DMA – 30 % water, from fitting to equation (6). SI is 
calculated based on Form I solubility.
SI DOSS / mg·mL-1
Molar ratio 
nDOSS/nMEF
J 
/m-3s-1
tg 
/s
1.99 0 0 104.2 1128
1.75 0 0 28.9 1638
1.75 1 0.08 26.8 1972
1.70 5 0.41 25.7 2259
1.53 0 0 8.6 5239
4.4. Calculation of pre-exponential factor and interfacial energy
In order to calculate the pre-exponential factor A and interfacial energy γ of the nucleation 
process, equation (5) can be rearranged using B’=B∙T3 as: 
 (8)
3 2
'ln ln
ln
J BA
S T S
 
This shows that a plot of ln (J/S) versus T-3ln-2 S should result in a straight line with an intercept 
of ln A and a slope of –B’. From B’, the interfacial energy, γ, can be calculated as:
 (9)
3 2
3
16'
3
mB
k
 
Figure 7a and Figure S7 in Supporting Information show this fit for the nucleation rates 
measured in 40 % DMA – 60 % water excluding and including SII=4.40 in the linear fit, 
respectively, whereas Figure 7b presents the plot in both solvent systems and shows the fit for 
pure MEF in 70 % DMA – 30 % water. The nucleation parameters calculated from the fits are 
summarized in Table 5. 
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In 40 % DMA – 60 % water, the nucleation parameters were calculated excluding and 
including the outlying SII=4.40 in the linear regression. Excluding SII=4.40 from the linear 
regression provided an excellent linear correlation for all the three systems (0.98 ≤ R2). From the 
fits, the pre-exponential factor A was calculated to be 1324 m-3s-1 in the absence of DOSS and 
increased to 2007 m-3s-1 and 1904 m-3s-1 with the addition of 0.1 mg/mL and 0.2 mg/mL DOSS, 
respectively. In contrast, the interfacial energy γ (with respect to Form II) was similar in the 
absence or presence of DOSS, being 2.92 – 3.00 mJm-2. Including SII=4.40, the fit was less good 
(0.91 ≤ R2) and the derived A and γ values did not show a clear trend with changing the 
concentration of DOSS from 0 to 0.2 mg/mL. Thus nucleation parameters at 40 % DMA – 60 % 
water are determined using the Poisson fit, excluding the data points at SII=4.40, which may 
deviate because uniformity of supersaturation might not have been achieved at the shortest 
induction times. The mixing of the solvent and antisolvent solutions is visually detectable for 
approximately 4 s after solution injection, and molecular level mixing should be somewhat longer 
than this. As a comparison, at the highest supersaturation of SII=4.40, the shortest induction time 
data is 16 s, whereas at the second highest supersaturation of SII=3.30 this data is 27 s, being 
considerable longer.
 As an estimation for the error of calculating the solubility of Form II and the corresponding 
SII from the mole fraction solubility ratio of xII/xI=1.4, A and γ values have been recalculated 
using xII /xI=1.3 or xII /xI=1.5. The obtained results are qualitatively the same, with A and γ values 
being 2.0-2.3 % smaller and 7.9 % larger at xII /xI=1.3, respectively, and 1.9-2.2 % larger and 7.4 
% smaller at xII /xI=1.5, respectively, and showing no influence of DOSS on γ.
As can be seen from Table 5, the same trend in Aa and similar γa values were found when the 
parameters were calculated from plotting the nucleation rates determined from fitting to LCDF 
(Ja) in the whole range of studied supersaturations, SII=2.20-4.40, as for A and γ over SII=2.20-
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3.30. This verifies that DOSS only has an effect on the pre-exponential factor with an 
insignificant influence on the interfacial energy. 
In previous recent work on tolbutamide34 survival theory analysis has been adopted for 
advanced evaluation of the statistical confidence of parameters obtained by fitting the classical 
nucleation theory to the same kind of nucleation data as in this study. In the study of tolbutamide 
in different solvents slopes and intercepts depending on the solvent were proven to be statistically 
different, except for between the two alcohols that also in the graph essentially overlapped. In the 
tolbutamide study 50-100 induction times were determined for each of three different 
supersaturations except for one case where there were four different supersaturations. In the 
present study on mefenamic acid 59-91 induction times were determined for each of three 
different supersaturations (SII=3.30-2.20) in 40 % DMA - 60 % water. Accordingly the statistical 
conditions are very similar, and based on this experience and the appearance of the classical 
nucleation theory plot (Figure 7a) we believe that it is reasonable to assume that there is a 
statistically valid difference in the nucleation behavior between the pure solution and the impure 
solutions.
In 70 % DMA – 30% water, in the absence of DOSS, the pre-exponential factor was found to 
be A=160 m-3s-1 and the interfacial energy was calculated to be γ = 2.86 mJm-2 with respect to 
Form I. The data points with 1 mg/mL DOSS at SI=1.75 and 5 mg/mL DOSS at SI=1.70 are lying 
along the fitted line of the pure system within experimental error, suggesting no influence on the 
nucleation of MEF. 
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Figure 7 Plot of ln (J/S) versus T-3ln-2S for the determination of the pre-exponential factor A and 
interfacial energy γ of the nucleation by fitting equation (8), showing (a) data points in 40 % 
DMA – 60 % water including data in the linear fit at SII=2.20-3.30 and (b) all data points and the 
fit for pure MEF in 70 % DMA – 30 % water. In 40 % DMA – 60 % water, Form II crystals 
nucleate and data is plotted using SII, whereas from 70 % DMA – 30 % water Form I crystals are 
isolated and data is plotted using SI.
Table 5. Pre-exponential factor, A, and the interfacial energy, γ, determined for the nucleation of 
MEF Form II in 40 % DMA – 60 % water and MEF Form I in 70 % DMA – 30 % water, in the 
absence or presence of DOSS. In 40 % DMA – 60 % water, fit was determined over SII=2.20-
4.40 or SII=2.20-3.30 and as a comparison, Aa and γa values obtained using Ja from the fit with 
LCDF are also included. 
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A
/m-3s-1
γ
/mJm-2 R
2 A
/m-3s-1
γ
/mJm-2 R
2 Aa
/m-3s-1
γa 
/mJm-2 R
2a
40 % DMA – 60 % water SII=2.20-4.40 SII=2.20-3.30 SII=2.20-4.40
Pure MEF 1800 3.25 0.91 1324 2.92 1.00 742.9 3.03 1.00
MEF + 0.1 mg/mL DOSS 1795 2.87 0.96 2007 3.00 0.98 928.0 3.02 0.99
MEF + 0.2 mg/mL DOSS 2099 3.07 0.99 1904 2.96 1.00 891.8 2.94 1.00
70 % DMA – 30 % water - SI=1.53-1.99 -
Pure MEF - 160 2.86 0.95 -
5. DISCUSSION 
The main objective of the present work is to investigate how the addition of DOSS influences 
the nucleation of MEF, and in particular to seek validation of the hypothesis that the reason why 
DOSS promotes the formation of nanocrystals of MEF in a 5% DMA – 95% water (S 
approximately in the order of 700018) antisolvent process is that DOSS promotes the nucleation 
of MEF under these conditions. The isothermal antisolvent crystallization protocol employed 
here, though being laborious, allowed for the rapid creation of uniform supersaturation and 
investigation of induction times as short as a couple of ten seconds, as opposed to the shortest 
induction times of ten minutes obtained in the traditional cooling crystallization experiments. The 
antisolvent experiments were performed at lower DMA content (40 %) and higher 
supersaturations: 2.20 ≤ SII ≤ 4.40, compared to the cooling crystallization experiments at 70 % 
DMA, and 1.53 ≤ SI ≤ 1.99. In the antisolvent experiments, being closer to the original 
nanocrystallization conditions18, the presence of 0.1 mg/mL and 0.2 mg/mL DOSS enhanced the 
nucleation of MEF crystals by increasing the pre-exponential factor A by approximately 50% 
(excluding the data points at SII=4.40), with no change in the interfacial energy γ.
Within the frame work of the classical nucleation theory, the increase in A in the presence of 
DOSS, observed in the 40 % DMA – 60 % water mixture, is the result of an increase of the 
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monomer attachment frequency or in the concentration of nucleation sites (f*C0) as the Zeldovich 
factor, equation (3), does not change since the interfacial energy has been shown to remain 
essentially unchanged. The attachment frequency parameter, given by equation (4), relates to the 
rate of transport of molecules to the critical nucleus surface and the likelihood of actually 
attaching and sticking to the surface. Thus it depends on the diffusion coefficient and the nucleus 
surface area. The latter remains unchanged if the interfacial energy is uninfluenced. Other 
parameters remain unchanged (molecular volume, equilibrium solute concentration, 
supersaturation, temperature) or are as a first approximation assumed to be unchanged (sticking 
coefficient) with the addition of DOSS in 40 % DMA – 60 % water. The diffusion process 
describes the transport of the solute molecules from the solution to the surface of the nucleus, and 
includes desolvation and required conformational changes. Thus, the increase in A in the presence 
of DOSS may reflect that the transport process is facilitated.
As shown in Figure 8, the mefenamic acid molecule has hydrogen bond accepting and 
donating functionalities, but also has large hydrophobic surface patches. In water, the MEF 
solubility is very low, because the hydrophobic parts of the molecule will force an entropically 
unfavorable structuring into the surrounding water molecules. The solubility is significantly 
improved by addition of DMA, but even in 40 % and 70 % by volume DMA – water mixtures the 
solubility of Form I is only about 0.065 mg/mL (0.27 mmol/L) at 25 °C and 3.8 mg/mL (15.7 
mmol/L) at 15 °C, respectively. 
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Figure 8 Molecular structure of water, DMA, MEF and DOSS, highlighting the type of 
functionalities in the molecules.
DMA is a polar aprotic solvent having a large dielectric constant and a sizeable dipole 
moment. The normalized solvent polarity parameter, , is 0.3835 and the octanol/water logP NTE
value is -0.7736. However, even though DMA and water are fully miscible, the solution is not 
well mixed on the molecular level37. At DMA in water concentrations of our previous 
nanocrystallization experiments: 5 % v/v DMA = 1.0 mole %; the tetrahedral structure of normal 
water predominates in the solution, and the radial distribution function (RDF) reveal the same 
data as in pure water. At the DMA concentration of the antisolvent nucleation experiments of the 
present study:  40 % v/v = 11.4 mole %, this water structure starts to disappear, and clusters of 
DMA molecules begin to form. DMA molecules aggregate with the dipole-dipole interactions 
between DMA molecules to form DMA clusters stabilized in water by the hydrophobic effect and 
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by strong hydrogen bonding with water over the carbonyl group. Thus in comparison, the force 
of interaction between DMA molecules is fairly weak. At the conditions of the cooling nucleation 
experiments of the present work: 70 % v/v DMA = 31.1 mole %, the RDF of pure DMA 
gradually dominates. Being an amphiphilic solvent, DMA has hydrophobicity in the methyl 
groups and can thus facilitate the solvation of the hydrophobic parts of MEF, which leads to 
increased solubility. However, in doing so, the DMA molecules partially have to order turning 
the polar side outwards, potentially hydrogen bonding with water. The unfavorable entropy 
decrease in the solvent molecules surrounding the hydrophobic parts of the MEF molecule should 
however be less than in pure water.
The docusate ion has hydrogen bond accepting functionality that may bond to water and MEF 
but there is no hydrogen bond donating functionality (Figure 8). The docusate ion has a large 
hydrophobic surface, and is expected to more favorably solvate the corresponding MEF 
molecular surface when introduced into the solution, and thus replace the less favorable solvation 
by water and DMA molecules. Hydrophobic interaction is not associated with particular forces 
between MEF and DOSS, and hence because of the weak interaction with DOSS the desolvation 
is facilitated. Accordingly, the attachment frequency factor becomes higher and the nucleation 
becomes facilitated. It appears as if it is more the role of the water that is important, since with 
increasing DMA content from 40 % to 70 %, the favourable effect on the nucleation of adding 
DOSS seems to disappear. 
As mentioned earlier, it has been hypothesized that DOSS promotes the formation of 
nanocrystals of MEF in a 5 % DMA – 95 % water 18. While, unfortunately, we do not have the 
experimental capability to investigate the rate of nucleation at the very high supersaturations in 5 
% DMA, the present work has shown that even at the very much lower supersaturations where 
we are capable of making actual nucleation experiments, a promoting effect can be detected. 
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Since the effect was found to relate to the large water content at 40 % DMA and decreases with 
increasing ratio of DMA in the solvent mixture, it is expected to be even stronger at 5 % DMA, 
thus supporting the hypothesis that DOSS promotes formation of smaller nanocrystals by 
increasing the rate of nucleation. 
It should be recognized though that in parallel to the increase in DMA content from 5 % to 70 
%, the supersaturation employed during the crystallization experiments also decreases perhaps 
even leading to a change from homogeneous to heterogeneous nucleation, and the polymorphic 
form nucleating possibly changed from the metastable Form II (5 %, 40 % DMA) to the stable 
Form I (70 % DMA). In addition, while the DOSS concentration employed in 40 % DMA – 60 % 
water system is only 0.1 - 0.2 mg/mL, the DOSS/MEF molar ratio is 0.14-0.54 (Table 2), which 
perhaps explains why the results do not show a significant influence of a two fold increase in 
DOSS concentration. 
Without the boundaries of the classical nucleation theory, the situation can be examined from 
a crystal structure point of view. The two structures of MEF feature the centrosymmetric 
hydrogen bonded dimerization, and the dimers are basically arranged in stacks linked through C-
H…pi interactions involving aromatic C-H and the alkylated phenyl ring38.These stacks are then 
arranged parallel in the crystal structure held together by van der Waals bonding. Presumably, the 
strongest bonding is the H-bonding between the carboxylic acid groups in the dimers, followed 
by the bonding between the dimers in the stack. The weakest bonding (per molecule) is likely to 
be that between the stacks. This agrees with vacuum crystal shape simulations within the 
Material studio software, using the attachment energy method39. The shape of Form I crystals is 
plate-like and the axis of the stacks is parallel to the big flat slow growing surface. 
In building the nucleus, we would expect the sequence: dimer formation, stacking and stack 
binding. In pure water the aggregation of MEF molecules should be significantly influenced by 
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hydrophobicity, i.e. reducing the exposure of the hydrophobic surfaces of the molecule to water. 
The dimer hydrogen bonding does not contribute to this, and thus dimers should not be expected 
to dominate in the solution. The hydrophobicity will somewhat promote the formation of the 
stacks, but will still leave a significant portion of the hydrophobic surface exposed. The binding 
of the stacks together will reduce the total hydrophobic surface area exposed to water. Adding 
DMA to a water solution will to some extent (as is illustrated by the increase in solubility) 
facilitate the solvation of the hydrophobic parts of MEF, and thus somewhat reduce the 
unfavorable conditions for dimer formation and stacking. Introducing docusate sodium into this 
may further facilitate dimerization and stacking of MEF molecules in the solution, and thus 
promote nucleation. 
In solvating the hydrophobic surface of MEF, DOSS will turn its own hydrophilic hydrogen 
bond accepting surface towards water/DMA. This will reduce the thermodynamically 
unfavorable contact between hydrophobicity and hydrophilicity, and facilitate the formation of 
dimers. If the formation of dimers is facilitated and become the units being transported, addition 
of DOSS will promote the nucleation. As no measurable decrease was observed in the solid-
liquid interfacial energy at these concentrations of DOSS (Table 5), the governing factor cannot 
be claimed to be improved solvation of the surface of the nucleus by DOSS. In relation to this, it 
is noteworthy that in 40 % DMA – 60 % water, the solubility of MEF in the presence of 0.2 
mg/mL DOSS is essentially unchanged from the value in the absence of DOSS (0.065 ± 0.001 
mg/mL and 0.065 ± 0.003 mg/mL respectively at 25 °C), and in the 70 % DMA – 30 % water 
mixture there is a very slight increase from 3.80 ± 0.01 mg/mL at 15 °C in pure solvent mixture 
to 3.92 ± 0.03 mg/mL in the presence of 5 mg/mL DOSS (Table1). 
Transport and attachment of molecules is required for both the formation of the critical 
nucleus as well as for the growth of the nuclei to detectable size. Accordingly, if the rate of 
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molecule attachment is governing, the increase in nucleation rate should correspond to a decrease 
in time for crystal nuclei to grow to become visible. In fact, in the present work, the growth time 
tg is decreased in the presence of DOSS in 40 % DMA – 60 % water over the entire 
supersaturation range examined. The same relation has been found previously40 for p-
aminobenzoic acid in different solvents, and it was concluded that desolvation of the carboxylic 
acid group and formation of carboxylic acid dimers is the rate limiting step for nucleation as well 
as for crystal growth. Studies showing molecular additives to increase the nucleation rate are 
rather scarce, but it has been found41 that tailor-made additives can accelerate the growth of γ-
glycine along the fast growing pole by disruption of the solvation, and that crystal growth of L-
alanine42 is accelerated in the presence of L-valine enhancing the rate of surface diffusion. 
Another possible mechanism for nucleation rate improvement in the presence of DOSS could 
be a templating effect of DOSS micelles or single DOSS ions, facilitating the arrangement of 
MEF molecules to form a nucleus and thus, increasing the pre-exponential factor A. However, in 
40 % DMA – 60 % water, micelle formation cannot be detected at the DOSS concentrations 
employed (Figure S8). In addition, an increasing nucleation promotion effect with increasing 
DOSS concentration would be expected if DOSS ions acted as nucleation centre which was not 
found at the concentrations examined here. 
6. CONCLUSION
In antisolvent crystallization at 40 % DMA – 60 % water and supersaturations of SII=4.40-
2.20, DOSS enhanced the nucleation rate of MEF. Within the classical nucleation theory, this 
increase is due to an increase in the pre-exponential parameter A by 52-44% at 0.1 mg/mL and 
0.2 mg/mL DOSS, respectively, while the interfacial energy γ remains essentially unchanged. 
The analysis leads to the hypothesis that the increase in A is due to an increase in the attachment 
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frequency of MEF molecules to the growing nucleus, as a result of a facilitated desolvation of 
MEF in the presence of DOSS. This is supported by the fact that also the time of growth to 
visibility tg is observed to decrease in the presence of DOSS. In the analysis, it is further 
recognised that DOSS may facilitate the formation of MEF dimers, a key element of the crystal 
structure. At 70 % DMA – 30 % water and supersaturations of SI=1.99-1.53, the influence of 
DOSS is very small, suggesting that it is in the presence of higher water concentrations that the 
influence of the surfactant DOSS is more clearly observed. 
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Promotion of Mefenamic Acid Nucleation by a Surfactant Additive, Docusate Sodium
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Synopses
Nucleation of mefenamic acid in the presence of an anionic additive, docusate sodium was 
enhanced in 40 % water - 60 % DMA mixture. 
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